Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Shenqi Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and manufacturing of Traditional Chinese Medicine (TCM) and chemical drugs. The company's operations include the No. 2 Pharmaceutical Factory, which is a key site for producing herbal-based injections and solid dosage forms. Their therapeutic focus spans oncology, cardiovascular diseases, respiratory conditions, and orthopedics, with well-known products such as Banzhilian Injection and Shenqi Capsules. As a publicly traded entity on the Shanghai Stock Exchange, the company plays a significant role in the regional economy of Guizhou and the broader Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Shenqi No 2 Herbs.